Gender-related differences in outcome after BMS or DES implantation in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: Insights from the DESERT cooperation

Atherosclerosis

Volumn 230, Issue 1, 2013, Pages 12-16

  De Luca, Giuseppe ^a,b   Verdoia, Monica ^a   Dirksen, Maurits T ^c   Spaulding, Christian ^d   Kelbæk, Henning ^e   Schalij, Martin ^f   Thuesen, Leif ^g   Hoeven, Bas van der ^f   Vink, Marteen A ^c   Kaiser, Christoph ^h   Musto, Carmine ⁱ   Chechi, Tania ^j   Spaziani, Gaia ^j   Diaz de la Llera, Luis Salvador ^k   Pasceri, Vincenzo ^l   Di Lorenzo, Emilio ^m   Violini, Roberto ⁱ   Suryapranata, Harry ⁿ   Stone, Gregg W ^o,p  

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^b UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^c ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e University of Copenhagen   (Denmark)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

^h UNIVERSITY HOSPITAL BASEL   (Switzerland)

ⁱ SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^j SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^k HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^l SAN FILIPPO NERI HOSPITAL   (Italy)

^m Division of Cardiology   (Italy)

ⁿ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^o Department of Medicine   (United States)

^p CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

more..

Author keywords

Drug eluting stent; Female gender; Primary angioplasty

Indexed keywords

ADULT; AGED; ANGIOPLASTY; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

DRUG-ELUTING STENT; FEMALE GENDER; PRIMARY ANGIOPLASTY;

AGED; ANGIOPLASTY; DATABASES, FACTUAL; DIABETES COMPLICATIONS; DISEASE-FREE SURVIVAL; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; ISCHEMIA; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEX FACTORS; STENTS; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 84881634098     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.05.024     Document Type: Article

References (21)

1. De Luca G., Cassetti E., Marino P. Percutaneous coronary intervention-related time delay, patient's risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction. Am J Emerg Med 2009, 27:712-719.
2. De Luca G., Biondi-Zoccai G., Marino P. Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials. Ann Emerg Med 2008, 52:665-676.
3. De Luca G., Suryapranata H., Stone G.W., Antoniucci D., Tcheng J.E., Neumann F.J., et al. Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAm Med Assoc 2005, 293:1759-1765.
4. De Luca G., Cassetti E., Verdoia M., Marino P. Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty: ameta-analysis of randomised trials. Thromb Haemost 2009, 102:428-436.
5. De Luca G., Navarese E.P., Suryapranata H. Ameta-analytic overview of thrombectomy during primary angioplasty. Int J Cardiol 2013, 166:E6-E12.
6. Weaver W.D., White H.D., Wilcox R.G., Aylward P.E., Morris D., Guerci A., et al. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy: GUSTO-I investigators. JAm Med Assoc 1996, 275:777-782.
7. Malacrida R., Genoni M., Maggioni A.P., Spataro V., Parish S., Palmer A., et al. Acomparison of the early outcome of acute myocardial infarction in women and men: the Third International Study of Infarct Survival Collaborative Group. NEngl J Med 1998, 338:8-14.
8. Vaccarino V., Parsons L., Every N.R., Barron H.V., Krumholz H.M. Sex-based differences in early mortality after myocardial infarction: National Registry of Myocardial Infarction 2 participants. NEngl J Med 1999, 341:217-225.
9. Vakili B.A., Kaplan R.C., Brown D.L. Sex-based differences in early mortality of patients undergoing primary angioplasty for first acute myocardial infarction. Circulation 2001, 104:3034-3038.
10. Antoniucci D., Valenti R., Moschi G., Migliorini A., Trapani M., Santoro G.M., et al. Sex-based differences in clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction. Am J Cardiol 2001, 87:289-293.
11. Brodie B.R. Why is mortality rate after percutaneous transluminal coronary angioplasty higher in women?. Am Heart J 1999, 137:582-584.
12. Vacek J.L., Rosamond T.L., Kramer P.H., Crouse L.J., Porter C.B., Robuck O.W., et al. Sex-related differences in patients undergoing direct angioplasty for acute myocardial infarction. Am Heart J 1993, 126:521-525.
13. De Luca G., Dirksen M.T., Spaulding C., Kelbaek H., Schalij M., Thuesen L., et al. Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials. Arch Intern Med 2012 Apr 23, 172(8):611-621. Drug-Eluting Stent in Primary Angioplasty (DESERT) Cooperation.
14. De Luca G., Suryapranata H., Dambrink J.H., Ottervanger J.P., van 't Hof A.W., Zijlstra F., et al. Sex-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty: data from the Zwolle Myocardial Infarction study. Am Heart J 2004, 148:852-856.
15. De Luca G., Gibson C.M., Gyöngyösi M., Zeymer U., Dudek D., Arntz H.R., et al. Gender-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. JThromb Thrombolysis 2010, 30:342-346.
16. Ferrante G., Presbitero P., Corrada E., Campo G., Bolognese L., Vassanelli C., et al. Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the multicenter evaluation of single high-dose bolus tirofiban versus abciximab with sirolimus-eluting stent or bare-metal stent in Acute Myocardial Infarction Study trial. Am Heart J 2012, 163:104-111.
17. Navarese E.P., Kubica J., Castriota F., Gibson C.M., De Luca G., Buffon A., et al. Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials. EuroIntervention 2011, 7:985-994.
18. Sabate M., Cequier A., Iñiguez A., Serra A., Hernandez-Antolin R., Mainar V., et al. Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial. Lancet 2012, 380:1482-1490.
19. Räber L., Kelbæk H., Ostojic M., Baumbach A., Heg D., Tüller D., et al. Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial. JAm Med Assoc 2012, 308:777-787. COMFORTABLE AMI Trial Investigators.
20. Wiviott S.D., Braunwald E., McCabe C.H., Horvath I., Keltai M., Herrman J.P., et al. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial. Lancet 2008, 371:1353-1363. TRITON-TIMI 38 Investigators.
21. Cannon C.P., Harrington R.A., James S., Ardissino D., Becker R.C., Emanuelsson H., et al. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. Lancet 2010, 375:283-293. PLATelet Inhibition and Patient Outcomes Investigators.